Clinical Trials Browser

Phase 1/2 × Burkitt Lymphoma × Injections × Clear all

NCT06580301 2026-02-06

Study of YK012 in B-cell Acute Lymphoblastic Leukemia

Phase 1/2 Recruiting

Burkitt Lymphoma

NCT05320380 2023-09-01

A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma